About Hemab

Hemab is a company that creates preventative treatments for bleeding and thrombosis problems. The medicines developed by the business aggregate, modify, balance, and at times recruit endogenous clotting components already present in the blood to the site of injury, allowing patients to produce hemostatic plugs or clots to avert life-threatening complications. Hemab Therapeutics was established in 2017 in Copenhagen, Hovedstaden by Johan H. Faber and Mads Behrndt.

Company Highlights
Year Founded

2019

icon-altEmployees

45

Location (HQ)

DNK

Since Last Funding

1 year 6 months

Monthly Website Visitors

2.1K

icon-altTotal Investment Amt

$200M

Last Funding Round

Series B

icon-altMoM Headcount Growth

2.27%

icon-altYoY Headcount Growth

45.02%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Pharmaceutical

Biotechnology

Life Science